Application YC di LEAH Labs

Winter 2019Active

LEAH Labs ha partecipato a Y Combinator nel batch Winter 2019 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2019
Settore: HealthcareTherapeutics
Dimensione team: 4
Stato: Active
Lanciata: 2018

Founder

Wesley WiersonFounder

Cosa fa LEAH Labs

LEAH Labs is building living therapies for pets first, and their people next. We're first focused on CAR-T cell therapy for dogs with B cell lymphoma, the naturally occurring clinical analog of human non-Hodgkin's lymphoma. CAR-T cells are curative in humans, and our early results are showing the same - we're inducing remissions in pets with late stage lymphomas. Our virus-free gene editing platform allows us to engineer a dose of CAR-T cell therapy for ~$500, and brings the promise of a curative outcome. Given our safety and efficacy data to date, we believe this product could be used by general practice veterinarians, meaning we have thousands of customers all across the USA who typically treat with palliative care or refer cancer patients to specialty oncologists. Our CAR-T cell platform is regulated by the USDA, not the FDA, affording us a cost effective "full stack" to iterate and innovate on CAR-T cell therapy from a hypothesis through clinical validation.

Application YC di LEAH Labs, ricostruita

Domanda per Y Combinator

LEAH Labs, batch Winter 2019. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

LEAH Labs

Describe what your company does in 50 characters or less.

Living therapies for pets first, people next

What is your company going to make? Please describe your product and what it does or will do.

We are building virus-free CAR-T cell therapies specifically for dogs with B cell lymphoma. Our product engineers living therapeutic cells that induce remission in pets, and we plan to extend this platform to human treatments later. The platform is designed to be cost-effective and usable by general practice veterinarians, expanding access to curative therapies outside specialty clinics.

Where do you live now, and where would the company be based after YC?

We currently live and work in Minneapolis, MN, and the company will remain based there after YC.

Explain your decision regarding location.

Minneapolis has strong biotech resources and because our founders are here, it's practical and cost-effective to stay. Being under USDA regulation rather than FDA lets us iterate faster even from this location.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di LEAH Labs?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di LEAH Labs (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come LEAH Labs si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva LEAH Labs?

LEAH Labs apparteneva al batch Winter 2019 di Y Combinator.

Chi ha fondato LEAH Labs?

LEAH Labs è stato fondato da Wesley Wierson.

Cosa fa LEAH Labs?

Living therapies for pets first, and their people next

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di LEAH Labs, e di ogni altro batch YC, è in YC Insights.